This GLP-1 receptor agonist, licensed for type 2 diabetes mellitus treatment in the UK, may trigger dizziness through several mechanisms including hypoglycaemia (particularly when combined with other diabetes medications), dehydration from gastrointestinal effects, or blood pressure changes
Systems biology studies: assessing tissue or regional receptor expression and pathway signatures using agonist stimulation frameworks
It encourages the release of insulin, cuts down on glucagon production, and makes food stay longer in your stomach
If you are coming from another medication and wondering about the transition, the semaglutide withdrawal symptom guide and switching medication guide address what happens when transitioning between different GLP-1 agonists
Malaysian Pharmacists Society president Amrahi Buang confirmed the shortage, attributing it to increased demand from non-diabetic individuals taking if for its weight loss effects
TSH: thyroid-stimulating hormone